Table 1 Characteristics and 131I dose of treated patients included in the study
Characteristic | All patients (n = 39) | Thyrotoxic patients (n = 16) | Thyroid cancer patients (n = 23) | p value |
|---|---|---|---|---|
Age, years | ||||
Mean ± SD | 43.4 ± 15.0 | 38.3 ± 13.7 | 69.9 ± 15.3 | 0.081 |
Range | 16.0–85.0 | 16.0–61.0 | 28.0–85.0 | |
Gender, n (%) | ||||
Male | 9 (23.1) | 6 (37.5) | 3 (13.0) | 0.075 |
Female | 30 (76.9) | 10 (62.5) | 20 (87.0) | |
Patient’s level of education, n (%) | ||||
Illiterate | 10 (25.6) | 2 (12.5) | 8 (34.8) | |
Primary | 5 (12.8) | 3 (18.8) | 2 (8.7) | |
High school | 13 (33.3) | 7 (43.8) | 6 (26.1) | 0.267 |
University | 10 (25.6) | 3 (18.8) | 7 (30.4) | |
Post-graduate | 1 (2.6) | 1 (6.3) | 0 (0) | |
Given 131I dose, MBq (mCi) | < 0.01* | |||
Range | 370–1110 (10–30) | 370–740 (10–20) | 1090–1110 (29.7–30) | |
Mean, MBq | 795 ± 329 (21.5 ± 8.9) | 527 ± 134 (14.2 ± 3.7) | 1099 ± 12 (29.7 ± 0.32) | |